Antiatherogenic small, dense HDL--guardian angel of the arterial wall?
about
Pitavastatin in cardiometabolic disease: therapeutic profileHigh density lipoprotein and metabolic disease: Potential benefits of restoring its functional propertiesDysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and LipidomicsGingival crevicular fluid as a source of biomarkers for periodontitisHDL particle number and size as predictors of cardiovascular diseaseThe Role of Different Monocyte Subsets in the Pathogenesis of Atherosclerosis and Acute Coronary SyndromesStatins in cardiometabolic disease: what makes pitavastatin different?Cholesterol: the good, the bad, and the ugly - therapeutic targets for the treatment of dyslipidemiaAssociation of serum retinol binding protein 4 with atherogenic dyslipidemia in morbid obese patientsStructural and Functional Analysis of the ApolipoproteinA-I A164S VariantIdentification of CETP as a molecular target for estrogen positive breast cancer cell death by cholesterol depleting agentsTemplated spherical high density lipoprotein nanoparticles.High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection.Loss of sex difference in high-density lipoprotein cholesterol in diabetic women during acute stress.Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors.Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH(2)Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function.High density lipoproteins and type 2 diabetes: Emerging concepts in their relationship.RGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probePrimary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis.The relationship between high density lipoprotein subclass profile and plasma lipids concentrationsRuminant-produced trans-fatty acids raise plasma total and small HDL particle concentrations in male Hartley guinea pigs.The impact of plasma triglyceride and apolipoproteins concentrations on high-density lipoprotein subclasses distribution.The Effect of apoM Polymorphism Associated with HDL Metabolism on Obese Korean Adults.HIV/hepatitis C virus coinfection ameliorates the atherogenic lipoprotein abnormalities of HIV infectionSmall high-density lipoprotein is associated with monocyte subsets in stable coronary artery diseaseDistinct HDL subclasses present similar intrinsic susceptibility to oxidation by HOCl.Low serum high density lipoprotein cholesterol concentration is an independent predictor for enhanced inflammation and endothelial activation.Dyslipidemia associated with chronic kidney diseaseBiochemical and functional characterization of charge-defined subfractions of high-density lipoprotein from normal adults.Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapyImpact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemiaHDL dysfunction in diabetes: causes and possible treatments.Impaired High-Density Lipoprotein Anti-Oxidant Function Predicts Poor Outcome in Critically Ill PatientsHigh Density Lipoprotein and it's DysfunctionRuminant-produced trans-fatty acids raise plasma HDL particle concentrations in intact and ovariectomized female Hartley guinea pigs.Operative risk factors in the metabolic syndrome: is it lipids and high blood pressure or are there direct vascular effects of insulin resistance and obesity?Invited commentary: lipoproteins and dementia - is it the apolipoprotein A-I?Mast cells: multipotent local effector cells in atherothrombosis.
P2860
Q21246037-19877688-0BF7-48D4-840B-BA9190310FBEQ26750603-0FD95126-A123-452F-AD0A-925BACD93705Q26774903-14A35454-B2FA-41EE-B9DE-79E4B0ED1F9DQ26776353-1351A9D5-056B-49A9-B09F-7082A2F54C21Q26779287-B6934DC4-3FA8-43B5-AC65-D834F486C603Q26852646-858D667F-5483-4CEE-990B-126FDF70E4CDQ27010638-5EE76AF3-8B60-42AE-8D08-B50ED195C9C9Q27013494-0F28811F-2803-4983-A0E5-B4FE3572F197Q28534795-FFE4DF39-8930-42BE-8980-76DD8A2B41C1Q28551157-8CA2767B-AE52-45DA-A575-21296A5BA799Q28821083-9801BDD9-C961-464A-B0E0-96A301185D2DQ33398727-A235DA5D-9450-4161-87E5-6B6C5D195C4AQ33556997-689A8866-AAD4-4C03-8541-42592B73AE6BQ33570203-703EA145-12B1-4E99-95EA-5830B1056E62Q33590777-054D5D37-DC21-48DA-9216-34906FE446CCQ33618352-56AD6307-8AFE-4FB7-A2B6-10A130EF036EQ33752486-3F965686-C569-4125-80AB-3F2753C77DBFQ33814212-A4343E49-750C-46A6-BAC7-2A9D5242602FQ33868758-C39AC903-C8DB-498C-B879-25D31D5EC5A8Q33972551-A3A13E30-266D-4D8F-B865-952191F86097Q34037325-EE8F4CE5-3241-43B5-BED8-7B8ACDE7DEEEQ34267570-50AB81CD-C6F4-40A7-92DD-7ABA047CFB67Q34308283-FD954F5E-AC47-4B61-A5F3-BA8CD1242EFBQ34564466-5B05E8FF-DF7E-4650-9D70-29F72F02FEDAQ34680936-58E97352-D801-4DDD-820C-83B64584B619Q34712485-59DB15E7-F3CC-4A6D-9D23-61DAB233F6E1Q34732457-18CE2BAF-C387-400E-9EA7-D791C05B7882Q34758389-3FE2CF50-F061-4DF3-9488-CFE68B2DD2B5Q35007253-4B0E93E0-9662-4BAF-8B2E-4AC3EA89BFF2Q35020237-21339443-E104-45D4-85B4-F391B7D7012BQ35028691-DE21200C-DF97-4F11-BF59-E08E9DBF0481Q35739667-38C70394-A68F-4FCA-A02C-EFAD633ED660Q35839693-C7135CAF-A07D-472C-BA44-625923303796Q35904110-40839414-C100-4FDA-896A-65CEFA6F7C97Q35957788-41F98951-3A65-49FA-ACE0-D6264EDF20ADQ36150462-59834AFF-2127-4A68-BE2D-ED062A5C86F9Q36160317-0F47E3C2-25BE-46E2-B2C1-CEAA9604ABFEQ36632433-E46B82F8-7E6E-4879-B77E-053773BCE05AQ36767859-FD584C5B-D6DB-492F-8F5E-4B7E6000758AQ36819891-BAF2D595-E61C-4647-89AC-10F79DF88F27
P2860
Antiatherogenic small, dense HDL--guardian angel of the arterial wall?
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Antiatherogenic small, dense HDL--guardian angel of the arterial wall?
@ast
Antiatherogenic small, dense HDL--guardian angel of the arterial wall?
@en
Antiatherogenic small, dense HDL--guardian angel of the arterial wall?
@nl
type
label
Antiatherogenic small, dense HDL--guardian angel of the arterial wall?
@ast
Antiatherogenic small, dense HDL--guardian angel of the arterial wall?
@en
Antiatherogenic small, dense HDL--guardian angel of the arterial wall?
@nl
prefLabel
Antiatherogenic small, dense HDL--guardian angel of the arterial wall?
@ast
Antiatherogenic small, dense HDL--guardian angel of the arterial wall?
@en
Antiatherogenic small, dense HDL--guardian angel of the arterial wall?
@nl
P356
P1476
Antiatherogenic small, dense HDL--guardian angel of the arterial wall?
@en
P2093
Anatol Kontush
M John Chapman
P2888
P304
P356
10.1038/NCPCARDIO0500
P577
2006-03-01T00:00:00Z
P5875
P6179
1037959152